Phase II Study of 99mTc-rhAnnexin V-128 Radionuclide Imaging in Patients With Clinical Suspicion or Confirmed Diagnosis of Spondyloarthritis (SpA)
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Tc-99m annexin V 128 (Primary)
- Indications Spondylarthritis
- Focus Diagnostic use; Proof of concept
- Sponsors Advanced Accelerator Applications
- 14 Jan 2019 Planned End Date changed from 1 Feb 2019 to 1 Oct 2019.
- 14 Jan 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Jun 2019.
- 26 Oct 2017 Status changed from not yet recruiting to recruiting.